The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
What Price Depression?: The Cost of Depression and the Cost-Effectiveness of Pharmacological Treatment
Abstract
The purpose of this study was twofold: to measure the overall direct costs of depression for 1990 in the UK, and to develop a model to illustrate issues in the evaluation of the relative cost-effectiveness of the pharmacological treatment of depression. We compared a tricyclic antidepressant, imipramine, with paroxetine, a newer antidepressant. For assessing the cost of illness, we used a top-down approach. We calculated direct but not indirect costs. Cost-effectiveness was evaluated by developing a simulation model based on the theory of clinical decision analysis to compare the costs and outcome of each treatment. From this we estimated the expected cost per patient and the cost per successfully treated patient. The total cost to the nation of depressive illness was estimated to be £222 million. The expected costs per patient were found to be similar for paroxetine and imipramine (£430 v. £424). The costs per successfully treated patient were found to be lower for paroxetine (£824) than for imipramine (£1024). The results were stable when a sensitivity analysis was applied to the variables employed in the model. The most sensitive variable was the cost of treatment failure. Our model thus reveals that medication that appears expensive in terms of cost per day may not be so when patient compliance and the total costs of treatment are taken into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Social adjustment by self-report in a community sample and in psychiatric outpatients
WEISSMAN, M. M., PRUSOFF, B. A., THOMPSON, W. D., HARDING, P. S., & MYERS, J. K. (1978) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197805000-00002 · Cited by 537
Quality-adjusted life years, utility theory, and healthy-years equivalents
Mehrez, A., & Gafni, A. (1989) · Medical Decision Making · doi:10.1177/0272989x8900900209 · Cited by 469
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Cited by
The economic burden of back pain in the UK
Maniadakis, N., & Gray, A. (2000) · Pain · doi:10.1016/s0304-3959(99)00187-6 · Cited by 1,510
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Cost of depression among adults in England in 2000
Thomas, C. M., & Morris, S. (2003) · British Journal of Psychiatry · doi:10.1192/00-000 · Cited by 310
Anderson, I. M., & Tomenson, B. M. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 306
Relative mortality from overdose of antidepressants
Henry, J. A., Alexander, C. A., & Sener, E. K. (1995) · BMJ · doi:10.1136/bmj.310.6974.221 · Cited by 290
Metadata
- Authors
- Jönsson, B., & Bebbington, P. E.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1994-05
- Volume
- 164
- Issue
- 5
- Pages
- 665-673
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2020571807
- Cited by
- 223
- References
- 3
- FWCI
- 96.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What Price Depression?: The Cost of Depression and the Cost-Effectiveness of Pharmacological Treatment. https://app.cochat.ai/papers/10.1192/bjp.164.5.665
- The paper
- Jönsson, B., & Bebbington, P. E. (1994). What Price Depression?: The Cost of Depression and the Cost-Effectiveness of Pharmacological Treatment. British Journal of Psychiatry. https://doi.org/10.1192/bjp.164.5.665
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.